IsoPlexis Completes $25 Million Series C Financing

By on , In the News

BRANFORD, Conn., May 14, 2019/PRNewswire/ — IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had raised $25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and […]